DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
HE3286 is an investigational drug.
There have been 5 clinical trials for HE3286. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2008.
The most common disease conditions in clinical trials are Insulin Resistance, Diabetes Mellitus, and Ulcer. The leading clinical trial sponsors are Harbor Therapeutics and [disabled in preview].
Recent Clinical Trials for HE3286
|A Study of the Safety, Tolerance and Assessment of HE3286 on Insulin Sensitivity and Hepatic Glucose Production||Harbor Therapeutics||Phase 1|
|Safety, Tolerance, Pharmacokinetics and Activity of HE3286 in Patients With Rheumatoid Arthritis||Harbor Therapeutics||Phase 1/Phase 2|
|Safety, Tolerance and Activity of HE3286 in Patients With Type 2 Diabetes Mellitus||Harbor Therapeutics||Phase 2|